Current Medicinal Chemistry

This journal supports open access

Editor-in-Chief:

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK

Back

Become EABM
Become Reviewer



Editorial [Hot Topic: Molecular Tools in Cancer Diagnosis and Therapy Guest Editor: Riyaz Basha] free to download

Volume:19   Issue:22
Pp: 3651-3652
Riyaz Basha
DOI: 10.2174/092986712801661086

Molecular Diagnostic Trends in Urological Cancer: Biomarkers for Non-Invasive Diagnosis

Volume:19   Issue:22
Pp: 3653-3663
V. Urquidi, C. J. Rosser and S. Goodison
DOI: 10.2174/092986712801661103

Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future

Volume:19   Issue:22
Pp: 3664-3678
N. B. Janakiram, A. Mohammed, M. S. Bronze and C. V. Rao
DOI: 10.2174/092986712801661022

Survivin as a Prognostic/Predictive Marker and Molecular Target in Cancer Therapy open access plus

Volume:19   Issue:22
Pp: 3679-3688
F. Rodel, T. Sprenger, B. Kaina, T. Liersch, C. Rodel, S. Fulda and S. Hehlgans
DOI: 10.2174/092986712801661040

Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer

Volume:19   Issue:22
Pp: 3689-3700
A. Passaro, A. Palazzo, P. Trenta, M. L. Mancini, F. Morano and E. Cortesi
DOI: 10.2174/092986712801661149

Early Detection and Prevention of Pancreatic Cancer: Use of Genetically Engineered Mouse Models and advanced Imaging Technologies

Volume:19   Issue:22
Pp: 3701-3713
A. Mohammed, N. B. Janakiram, S. Lightfoot, H. Gali, A. Vibhudutta and C. V. Rao
DOI: 10.2174/092986712801661095

Combinatorial Nanoparticles for Cancer Diagnosis and Therapy open access plus

Volume:19   Issue:22
Pp: 3714-3721
A. Mukerjee, A. P. Ranjan and J. K. Vishwanatha
DOI: 10.2174/092986712801661176

In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment

Volume:19   Issue:22
Pp: 3730-3738
Z. Jehan, S. Uddin and K. S. Al-Kuraya
DOI: 10.2174/092986712801661031

Homeostasis and the Importance for a Balance Between AKT/mTOR Activity and Intracellular Signaling open access plus

Volume:19   Issue:22
Pp: 3748-3762
D. A. Altomare and A. R. Khaled
DOI: 10.2174/092986712801661130

Structure and Ligand Based Drug Design Strategies in the Development of Novel 5- LOX Inhibitors open access plus

Volume:19   Issue:22
Pp: 3763-3778
Polamarasetty Aparoy, Kakularam Kumar Reddy and Pallu Reddanna
DOI: 10.2174/092986712801661112

Expression of Specificity Protein Transcription Factors in Pancreatic Cancer and their Association in Prognosis and Therapy

Volume:19   Issue:22
Pp: 3779-3786
Umesh T. Sankpal, Pius Maliakal, Debashish Bose, Omar Kayaleh, Daniel Buchholz and Riyaz Basha
DOI: 10.2174/092986712801661077

Cellular Therapy for Ovarian Cancer: Experimental and Clinical Perspectives

Volume:19   Issue:22
Pp: 3787-3793
Susan B. Ingersoll, Sarfraz Ahmad, Neil J. Finkler, John R. Edwards and Robert W. Holloway
DOI: 10.2174/092986712801661158

The Use of Therapeutic Peptides to Target and to Kill Cancer Cells

Volume:19   Issue:22
Pp: 3794-3804
R. J. Boohaker, M. W. Lee, P. Vishnubhotla, J.L. M. Perez and A. R. Khaled
DOI: 10.2174/092986712801661004

Melatonin, A Natural Programmed Cell Death Inducer in Cancer

Volume:19   Issue:22
Pp: 3805-3821
M. Sánchez-Hidalgo, J. M. Guerrero, I. Villegas, G. Packham and C. A. de la Lastra
DOI: 10.2174/092986712801661013

New Therapeutic Approaches by Using Microorganism-Derived Compounds

Volume:19   Issue:22
Pp: 3822-3840
A. Amedei and M. M. D'Elios
DOI: 10.2174/092986712801661167

Approaches to Target Profiling of Natural Products

Volume:19   Issue:22
Pp: 3841-3855
R. Yue, L. Shan, X. Yang and W. Zhang
DOI: 10.2174/092986712801661068